ArticlePolymers2021
Pyrolysis Kinetic Behaviour of Glass Fibre-Reinforced Epoxy Resin Composites Using Linear and Nonlinear Isoconversional Methods.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Article
- Pyrolysis Kinetic Behavior and Thermodynamic Analysis of PET Nonwoven Fabric.Materials (Basel, Switzerland) · 2023Article
- A Modified Langmuir Model for Moisture Diffusion in UGFRE of Composite Insulator Considering the Composite Degradation.Polymers · 2022Article
- Pyrolysis Evaluation of Tennis String Polyurethane and Water-Borne Polyurethane Wastes through Isoconversional Kinetic Analysis.Polymers · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the increasing demand for glass fibre-reinforced epoxy resin composites (GFRC), huge amounts of GFRC waste are produced annually in different sizes and shapes, which may affect its thermal and chemical decomposition using pyrolysis technology. In this context, this research aims to study the effect of mechanical pre-treatment on the pyrolysis behaviour of GFRC and its pyrolysis kinetic. The experiments were started with the fabrication of GFRC panels using the vacuum-assisted resin transfer method followed by crushing the prepared panels using ball milling, thus preparing the milled GFRC with uniform shape and size. The elemental, proximate, and morphology properties of the panels and milled GFRC were studied. The thermal and chemical decomposition of the milled GFRC was studied using thermogravimetric coupled with Fourier-transform infrared spectroscopy (TG-FTIR) at different heating rates. Meanwhile, the volatile products were examined using TG coupled with gas chromatography-mass spectrometry (GC-MS). The TG-FTIR and TG-GC-MS experiments were performed separately. Linear (Kissinger-Akahira-Sunose (KAS), Flynn-Wall-Ozawa (FWO), and Friedman) and nonlinear (Vyazovkin and Cai) isoconversional methods were used to determine the pyrolysis kinetic of the milled GFRC based on thermogravimetry and differential thermal gravimetry (TG/DTG). In addition, the TG/DTG data of the milled GFRC were fitting using the distributed activation energy model and the independent parallel reactions kinetic model. The TG results showed that GFRC can decompose in three stages, and the main decomposition is located in the range 256-500 °C. On the other hand, aromatic benzene and a C-H bond were the major functional groups in the released volatile components in FTIR spectra, while phenol (27%), phenol,4-(1-methylethyl) (40%), and p-isopropenylphenol (34%) were the major compounds in GC-MS analysis. Whereas, the kinetic results showed that both isoconversional methods can be used to determine activation energies, which were estimated 165 KJ/mol (KAS), 193 KJ/mol (FWO), 180 KJ/mol (Friedman), 177 KJ/mol (Vyazovkin), and 174 KJ/mol (Cai).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.